<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Neonatal Screen</journal-id><journal-id journal-id-type="iso-abbrev">Int J Neonatal Screen</journal-id><journal-id journal-id-type="publisher-id">IJNS</journal-id><journal-title-group><journal-title>International Journal of Neonatal Screening</journal-title></journal-title-group><issn pub-type="epub">2409-515X</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40407521</article-id><article-id pub-id-type="pmc">PMC12101202</article-id>
<article-id pub-id-type="doi">10.3390/ijns11020038</article-id><article-id pub-id-type="publisher-id">IJNS-11-00038</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Newborn Screening for Congenital Heart Disease: A Five-Year Study in Shanghai</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-1408-7306</contrib-id><name><surname>Tian</surname><given-names>Youping</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x02013; original draft</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role><xref rid="af1-IJNS-11-00038" ref-type="aff">1</xref><xref rid="fn1-IJNS-11-00038" ref-type="author-notes">&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>Gu</surname><given-names>Qing</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review &#x00026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="af1-IJNS-11-00038" ref-type="aff">1</xref><xref rid="af2-IJNS-11-00038" ref-type="aff">2</xref><xref rid="fn1-IJNS-11-00038" ref-type="author-notes">&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>Hu</surname><given-names>Xiaojing</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review &#x00026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="af1-IJNS-11-00038" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Ge</surname><given-names>Xiaoling</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review &#x00026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="af1-IJNS-11-00038" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Ma</surname><given-names>Xiaojing</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review &#x00026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="af1-IJNS-11-00038" ref-type="aff">1</xref><xref rid="af2-IJNS-11-00038" ref-type="aff">2</xref><xref rid="af3-IJNS-11-00038" ref-type="aff">3</xref><xref rid="af4-IJNS-11-00038" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name><surname>Yang</surname><given-names>Miao</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review &#x00026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="af1-IJNS-11-00038" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Jia</surname><given-names>Pin</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review &#x00026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="af1-IJNS-11-00038" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Jing</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review &#x00026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="af5-IJNS-11-00038" ref-type="aff">5</xref></contrib><contrib contrib-type="author"><name><surname>Yang</surname><given-names>Lulu</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review &#x00026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="af5-IJNS-11-00038" ref-type="aff">5</xref></contrib><contrib contrib-type="author"><name><surname>Zhao</surname><given-names>Quming</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review &#x00026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="af2-IJNS-11-00038" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Fang</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review &#x00026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="af2-IJNS-11-00038" ref-type="aff">2</xref><xref rid="af3-IJNS-11-00038" ref-type="aff">3</xref><xref rid="af4-IJNS-11-00038" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name><surname>Ye</surname><given-names>Ming</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review &#x00026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="af2-IJNS-11-00038" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Yang</surname><given-names>Yulin</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review &#x00026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role><xref rid="af5-IJNS-11-00038" ref-type="aff">5</xref><xref rid="c1-IJNS-11-00038" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Huang</surname><given-names>Guoying</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review &#x00026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role><xref rid="af1-IJNS-11-00038" ref-type="aff">1</xref><xref rid="af2-IJNS-11-00038" ref-type="aff">2</xref><xref rid="af3-IJNS-11-00038" ref-type="aff">3</xref><xref rid="af4-IJNS-11-00038" ref-type="aff">4</xref><xref rid="c1-IJNS-11-00038" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Webster</surname><given-names>Dianne</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-IJNS-11-00038"><label>1</label>National Management Office of Neonatal Screening Project for Congenital Heart Disease, Children&#x02019;s Hospital of Fudan University, National Children&#x02019;s Medical Center, Shanghai 201102, China</aff><aff id="af2-IJNS-11-00038"><label>2</label>Pediatric Heart Center, Children&#x02019;s Hospital of Fudan University, National Children&#x02019;s Medical Center, Shanghai 201102, China</aff><aff id="af3-IJNS-11-00038"><label>3</label>Research Unit of Early Intervention of Genetically Related Childhood Cardiovascular Diseases (2018RU002), Chinese Academy of Medical Sciences, Shanghai 201102, China</aff><aff id="af4-IJNS-11-00038"><label>4</label>Shanghai Key Laboratory of Birth Defects, Shanghai 201102, China</aff><aff id="af5-IJNS-11-00038"><label>5</label>Shanghai Center for Women and Children Health, Shanghai 200062, China</aff><author-notes><corresp id="c1-IJNS-11-00038"><label>*</label>Correspondence: <email>yangyulin@shwch.org.cn</email> (Y.Y.); <email>gyhuang@shmu.edu.cn</email> (G.H.)</corresp><fn id="fn1-IJNS-11-00038"><label>&#x02020;</label><p>These authors contributed equally to this work.</p></fn></author-notes><pub-date pub-type="epub"><day>17</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>6</month><year>2025</year></pub-date><volume>11</volume><issue>2</issue><elocation-id>38</elocation-id><history><date date-type="received"><day>14</day><month>3</month><year>2025</year></date><date date-type="rev-recd"><day>18</day><month>4</month><year>2025</year></date><date date-type="accepted"><day>12</day><month>5</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; 2025 by the authors.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Published by MDPI on behalf of the International Society for Neonatal Screening. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>This study aimed to report the progress and results of the newborn screening program for congenital heart disease (CHD) in south Shanghai between 2019 and 2023, and to evaluate the accuracy of the dual-index method (pulse oximetry (POX) plus cardiac murmur auscultation) in clinical practice. Between 2019 and 2023, a total of 198,606 (99.89%) newborns were screened for CHD, of whom 3299 (1.66%) tested positive, 3043 (92.24%) underwent echocardiography for CHD diagnosis and 1109 were diagnosed with CHD in a timely manner. Among 195,307 infants with negative screening results using the dual-index method, 139 (0.07%) were later diagnosed with CHD, and none of these infants died. More than half of these false-negative infants (59.39%) were identified due to the detection of a heart murmur during routine physical examinations within six months after birth. Compared to POX testing alone, the dual-index method significantly improved the sensitivity of screening for CHD, and kept high specificity in clinical practice. This study demonstrated that newborn screening for CHD has been well conducted in Shanghai, and the dual-index method had high accuracy and reliability for neonatal CHD screening in clinical practice.</p></abstract><kwd-group><kwd>congenital heart disease</kwd><kwd>newborn screening</kwd><kwd>dual-index method</kwd><kwd>Shanghai</kwd></kwd-group><funding-group><award-group><funding-source>National Key Research and Development Program of China</funding-source><award-id>2016YFC1000500</award-id><award-id>2021YFC2701004</award-id></award-group><award-group><funding-source>National Natural Science Foundation of China</funding-source><award-id>82270312</award-id></award-group><award-group><funding-source>Shanghai Science and Technology Innovation Action Plan&#x02014;Technical Standard Project</funding-source><award-id>23DZ2203000</award-id><award-id>24DZ2202800</award-id></award-group><award-group><funding-source>Shanghai Health Commission of Health Industry Clinical Research Project</funding-source><award-id>20234Y0211</award-id></award-group><award-group><funding-source>Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences</funding-source><award-id>2019-I2M-5-002</award-id></award-group><funding-statement>This research was funded by the National Key Research and Development Program of China (grant numbers 2016YFC1000500 and 2021YFC2701004), the National Natural Science Foundation of China (grant number 82270312), the Shanghai Science and Technology Innovation Action Plan&#x02014;Technical Standard Project (23DZ2203000, 24DZ2202800), the Shanghai Health Commission of Health Industry Clinical Research Project (20234Y0211), and the Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences (2019-I2M-5-002).</funding-statement></funding-group></article-meta></front><body><sec sec-type="intro" id="sec1-IJNS-11-00038"><title>1. Introduction</title><p>Congenital heart disease (CHD) can affect approximately 150,000 births per year in China [<xref rid="B1-IJNS-11-00038" ref-type="bibr">1</xref>], and is a leading cause of infant death [<xref rid="B2-IJNS-11-00038" ref-type="bibr">2</xref>]. Approximately one-third of these patients have life-threatening major CHD, which requires surgery or invasive intervention within the first year of life to prevent severe complications and death [<xref rid="B3-IJNS-11-00038" ref-type="bibr">3</xref>]. Almost all life-threatening major CHD cases can be corrected if diagnosed and intervened in a timely manner, while delayed diagnosis is associated with severe complications, including acute cardiovascular collapse, heart failure, hypoxemia-induced acidosis, hypoxic&#x02013;ischemic brain damage, recurrent pneumonia and infant death [<xref rid="B4-IJNS-11-00038" ref-type="bibr">4</xref>,<xref rid="B5-IJNS-11-00038" ref-type="bibr">5</xref>]. Therefore, the early detection of life-threatening major CHD is critical during the neonatal period.</p><p>Pulse oximetry (POX) is an easily accessible noninvasive test [<xref rid="B6-IJNS-11-00038" ref-type="bibr">6</xref>], and has been demonstrated to improve early detection of critical CHD (CCHD), thereby improving outcomes for affected newborns [<xref rid="B7-IJNS-11-00038" ref-type="bibr">7</xref>]. Our previous studies also demonstrated that POX is an effective screening method for CCHD with moderate sensitivity and high specificity in China, and additionally found that POX plus cardiac murmur auscultation (namely dual-index method) can significantly improve the detection rate of both CCHD and life-threatening major CHD during the early neonatal stage [<xref rid="B8-IJNS-11-00038" ref-type="bibr">8</xref>,<xref rid="B9-IJNS-11-00038" ref-type="bibr">9</xref>]. To reduce infant mortality and under-five mortality, the Shanghai Municipal Health Commission implemented newborn screening for CHD using the dual-index method in all birthing facilities, and established a systematic network to cover the entire city with partition management for screening, diagnosis and treatment in 2016 [<xref rid="B10-IJNS-11-00038" ref-type="bibr">10</xref>].</p><p>The Children&#x02019;s Hospital of Fudan University, a large Grade A tertiary hospital (the highest level in China&#x02019;s hospital classification system) located in the Minhang District of Shanghai, pioneered the dual-index method and demonstrated its accuracy and feasibility during the birth hospitalization. As one of the four diagnosis and treatment centers for CHD in Shanghai, the Children&#x02019;s Hospital of Fudan University is responsible for the management, training and quality control of newborn screening program for CHD in the south Shanghai including five administrative districts (Xuhui, Minhang, Songjiang, Jinshan and Qingpu). The primary objective of this study was to update the progress and results of the newborn screening program for CHD in these five districts between 2019 and 2023. And the secondary aim was to evaluate the accuracy of the dual-index method and its continued impact on CHD detection in clinical practice, including an assessment of postnatally diagnosed CHD cases undetected by the dual-index method, over a five-year period in all delivery hospitals in the south Shanghai.</p></sec><sec id="sec2-IJNS-11-00038"><title>2. Materials and Methods</title><sec sec-type="subjects" id="sec2dot1-IJNS-11-00038"><title>2.1. Study Design and Participants</title><p>This was a five-year retrospective cohort study involving all live births delivered at hospitals in the five districts of Shanghai from 1 January 2019 to 31 December 2023. The study included all consecutive newborns who participated in CHD screening using the dual-index method, regardless of gestational age or neonatal intensive care unit (NICU) admission status. Newborns who did not receive routine screening (e.g., parent refusal) were excluded from the present study (N = 219).</p><p>Before and after delivery, trained medical staff provided education for all participants&#x02019; parents and families regarding the risks of CHD, benefits and limitations of newborn screening for CHD, as well as short- and long-term follow-up recommendations. All participants&#x02019; parents gave written informed consent for their children before participating in newborn screening for CHD. This study was approved by the ethics committee of the Children&#x02019;s Hospital of Fudan University.</p></sec><sec sec-type="methods" id="sec2dot2-IJNS-11-00038"><title>2.2. Procedures</title><p>The screening methodology and procedures have been described in detail elsewhere [<xref rid="B9-IJNS-11-00038" ref-type="bibr">9</xref>,<xref rid="B10-IJNS-11-00038" ref-type="bibr">10</xref>]. Briefly, screening for CHD was performed in newborn babies aged 6&#x02013;72 h. Cardiac murmur auscultation was conducted by a trained pediatrician in a quiet room using a stethoscope appropriate for newborns prior to POX screening to ensure that the auscultation result is not affected by noise or the POX result. Then, a trained nurse or pediatrician conducted POX screening using a pulse oximeter with a multisite sensor to measure oxygen saturations from the babies&#x02019; right hand and either foot. Dual-index screening for CHD was defined as positive if (a) cardiac murmur is grade II or above, (b) the pulse oximeter oxygen saturation (SpO<sub>2</sub>) is less than 90% in the right hand or either foot, (c) the SpO<sub>2</sub> is less than 95% in the right hand or either foot on two measurements separated by 2~4 h or (d) a difference between the two extremities is more than 3% on two measurements, separated by 2~4 h. Standardized training and on-site supervision are conducted at least twice each year for medical staff in birthing facilities to ensure the accuracy and reliability of screening results and data registrations [<xref rid="B10-IJNS-11-00038" ref-type="bibr">10</xref>].</p><p>For newborns with positive screening results, clinicians immediately informed their parents of the necessity for echocardiography to rule out CHD. In accordance with the requirements of the Shanghai Newborn Congenital Heart Disease Screening Program [<xref rid="B10-IJNS-11-00038" ref-type="bibr">10</xref>], newborns who screened positive using the dual-index method were referred to the Children&#x02019;s Hospital of Fudan University or other diagnosis and treatment centers for echocardiography within one week, and those diagnosed with CHD were further evaluated by pediatric cardiac experts. For infants with negative screening results, clinical follow-up and physical examinations were conducted at local community hospitals at 6 weeks, 3 months and 6 months of age, in combination with feedbacks from parents about cardiac symptoms such as cyanosis, tachypnea and feeding difficulty or medical chart review. Newborns diagnosed without CHD will stay in the track of Child Health Management, a basic public health service program for children under seven years of age in China [<xref rid="B10-IJNS-11-00038" ref-type="bibr">10</xref>].</p><p>During the COVID-19 pandemic, Shanghai implemented a range of effective policies (e.g., nucleic acid testing, vaccination availability, standard infection control measures) to ensure the safety of pregnant and postpartum women during childbirth, balancing infection control with the continuity of essential maternity care [<xref rid="B11-IJNS-11-00038" ref-type="bibr">11</xref>,<xref rid="B12-IJNS-11-00038" ref-type="bibr">12</xref>].</p></sec><sec id="sec2dot3-IJNS-11-00038"><title>2.3. Data Source</title><p>The Information Management System of Newborn Screening for CHD (<uri xlink:href="www.nchd.org.cn">www.nchd.org.cn</uri> accessed on 16 May 2025) was used daily to register and track the results of CHD screening, diagnosis, and treatment. All delivery hospitals registered information on maternal and neonatal demographic characteristics (e.g., maternal name, maternal resident identity card, infant name, sex and birth date) and screening results (including the screening date, SpO<sub>2</sub> values and grade of cardiac murmur). The Children&#x02019;s Hospital of Fudan University uploaded echocardiography, and registered the results of diagnosis (including the diagnosis date, and CHD classification) and treatment (including the date, method and outcome of surgery or interventional catheterization) in this electronic registration system.</p></sec><sec id="sec2dot4-IJNS-11-00038"><title>2.4. Defining Outcomes</title><p>As suggested by previous studies [<xref rid="B8-IJNS-11-00038" ref-type="bibr">8</xref>,<xref rid="B13-IJNS-11-00038" ref-type="bibr">13</xref>], CHD were classified as critical (requiring intervention or causing death within 28 days of age), serious (requiring intervention before 1 year of age, but not classified as critical), significant (defects persist longer than 6 months of age, but not classified as critical or serious), and non-significant (defects are not physically appreciable and do not persist after 6 months of age). For the purpose of the study analyses, we defined critical and serious CHD as life-threatening major CHD, while the remaining categories were classified as minor CHD.</p><p>In this study, the following conditions were excluded from the definition of CHD: (1) patent ductus arteriosus that closed spontaneously within 3 months, (2) atrial septal defect (ASD)&#x02009; &#x0003c; 5&#x02009;mm in diameter at 3 months of age, (3) physiological pulmonary branch stenosis that resolved during follow-up, (4) pulmonary stenosis or aortic stenosis with a pressure gradient of &#x0003c;20&#x02009;mmHg without further deterioration during follow-up and (5) simple patent foramen ovale [<xref rid="B3-IJNS-11-00038" ref-type="bibr">3</xref>].</p></sec><sec id="sec2dot5-IJNS-11-00038"><title>2.5. Statistical Analyses</title><p>The results of newborn screening for CHD in each district per year are presented using the following key indicators: (1) screening rate = number of newborns screened/number of live births &#x000d7; 100%; (2) screened positive rate = number of newborns screened positive/number of newborns screened &#x000d7; 100%; (3) echocardiography examination rate = number of echocardiography in newborns screened positive/number of newborns screened positive &#x000d7; 100%; (4) diagnostic rate of CHD in newborns screened positive = number of newborns diagnosed with CHD in those screened positive/number of newborns screened positive &#x000d7; 100%; (5) CHD prevalence = number of CHD cases/number of live births &#x000d7; 100%.</p><p>We calculated the sensitivity, specificity, false-positive rate, positive and negative predictive value, consistency rate, Youden&#x02019;s index and positive and negative likelihood ratios for both the dual-index method and POX alone in newborn screening for CHD. The Wilson method was used to calculate the 95% confidence interval (95% CI) of sensitivity and specificity. Additionally, we described the false-negative results of the dual-index method. All statistical analyses were performed using SAS 9.4 (SAS Institute Inc., Cary, NC, USA).</p></sec></sec><sec sec-type="results" id="sec3-IJNS-11-00038"><title>3. Results</title><sec id="sec3dot1-IJNS-11-00038"><title>3.1. Results of Newborn Screening for CHD in South Shanghai</title><p>From 1 January 2019 to 31 December 2023, a total of 198,606 (99.89%) newborns were screened for CHD using the dual-index method across the five districts of south Shanghai (<xref rid="IJNS-11-00038-t001" ref-type="table">Table 1</xref> and <xref rid="IJNS-11-00038-f001" ref-type="fig">Figure 1</xref>). The annual CHD screening rate has exceeded 99% in all districts (<xref rid="IJNS-11-00038-f002" ref-type="fig">Figure 2</xref>). Among the 198,606 newborns screened, 3299 (1.66%) tested positive, of whom 3043 (92.24%) underwent echocardiography for CHD diagnosis (<xref rid="IJNS-11-00038-t001" ref-type="table">Table 1</xref>). The echocardiography examination rate increased from 85.63% in 2019 to 97.51% in 2023 (<xref rid="IJNS-11-00038-t001" ref-type="table">Table 1</xref>), demonstrating an upward trend in nearly all districts (<xref rid="IJNS-11-00038-f002" ref-type="fig">Figure 2</xref>).</p><p>A total of 1109 (33.62%) screen-positive newborns were diagnosed with CHD, including 73 CCHD, 133 serious CHD and 903 minor CHD (<xref rid="IJNS-11-00038-f001" ref-type="fig">Figure 1</xref>). As presented in <xref rid="IJNS-11-00038-t002" ref-type="table">Table 2</xref>, CCHD cases included pulmonary atresia (n = 20), total anomalous pulmonary venous drainage (n = 16), coarctation of the aorta (n = 11), transposition of the great arteries (n = 10), critical pulmonary stenosis (n = 7), interrupted aortic arch (n = 3), double outlet right ventricle (n = 2), hypoplastic left heart syndrome (n = 2) and single ventricle (n = 2). Serious CHD cases included ventricular septal defect (n = 71), Tetralogy of Fallot (n = 20), pulmonary stenosis (n = 18), patent ductus arteriosus (n = 15), atrioventricular septal defect (n = 6), coarctation of the aorta (n = 2) and partial anomalous pulmonary venous connection (n = 1).</p></sec><sec id="sec3dot2-IJNS-11-00038"><title>3.2. CHD in Infants with Negative Screening Results of the Dual-Index Method</title><p>Among 195,307 infants with negative screening results from the dual-index method, 139 (0.07%) were subsequently diagnosed with CHD. More than half of these false-negative infants (59.39%) were identified due to the detection of a heart murmur during routine physical examinations within six months after birth. The remaining cases were diagnosed through echocardiography, which was arranged for conditions such as preterm birth, low birth weight, pneumonia or other medical concerns.</p><p>Fortunately, among these 139 infants, none were diagnosed with CCHD, and 33 infants were diagnosed with serious CHD requiring surgery before the age of one year. These cases included patent ductus arteriosus (n = 17), ventricular septal defect (n = 12), atrioventricular septal defect (n = 1), coarctation of the aorta (n = 1), cor triatriatum (n = 1) and partial anomalous pulmonary venous connection (n = 1, <xref rid="IJNS-11-00038-t002" ref-type="table">Table 2</xref>). There were no deaths among infants with negative screening results using the dual-index method.</p></sec><sec id="sec3dot3-IJNS-11-00038"><title>3.3. Accuracy of Screening Methods for CCHD and Life-Threatening Major CHD</title><p>The accuracy of POX and the dual-index method for the detection of CCHD, life-threatening major CHD, and all types of CHD is presented in <xref rid="IJNS-11-00038-t003" ref-type="table">Table 3</xref>. In this retrospective cohort, POX alone as a screening method was able to identify 62 of 73 (84.93%) cases of CCHD, but only 91 of 239 (38.08%) cases of major CHD. The specificity of POX was 99.57% and 99.59% for CCHD and life-threatening major CHD, respectively. The dual-index method could detect 73 of 73 (100.00%) cases of CCHD and 206 of 239 (86.19%) cases of life-threatening major CHD. Compared to POX testing alone, the dual-index method significantly improved the sensitivity of screening for CCHD and life-threatening major CHD. Additionally, the dual-index method could achieve similarly high specificities (CCHD: 98.38%, major CHD: 98.44%), and had similarly high consistency rates.</p><p>The positive predictive value of POX was 6.79% for CCHD and 9.97% for life-threatening major CHD, while the positive predictive value of the dual-index method was 2.21% for critical CHD, and 6.24% for life-threatening major CHD.</p></sec></sec><sec sec-type="discussion" id="sec4-IJNS-11-00038"><title>4. Discussion</title><p>Using real-world data from a five-year clinical practice, this study detailed the progress and results of the newborn screening program for CHD in the five administrative districts of south Shanghai between 2019 and 2023, and evaluated the accuracy and reliability of the dual-index method and its continued impact on CHD detection in clinical practice. Nearly all live births in these five districts were screened for CHD using the dual-index method, and the echocardiography examination rate and diagnostic rate of CHD in newborns screened positive have reached 92.24% and 33.62%, respectively. Furthermore, this study confirmed that the dual-index method had high sensitivities and specificities for detecting both CCHD and life-threatening major CHD in clinical practice.</p><p>Between 2019 and 2023, almost all newborns were screened for CHD using the dual-index method in the five administrative districts of south Shanghai, and the annual screening rate for CHD has exceeded 99% in all five districts. The mean screened positive rate (1.66%) was consistent with findings from our previous multicenter screening studies [<xref rid="B8-IJNS-11-00038" ref-type="bibr">8</xref>,<xref rid="B9-IJNS-11-00038" ref-type="bibr">9</xref>]. The echocardiography examination rate among newborns who screened positive in the south Shanghai was 92.24%, showing an upward trend from 85.63% in 2019 to 97.51% in 2023, which was higher than the citywide average (89.88%) between 2017 and 2021 [<xref rid="B10-IJNS-11-00038" ref-type="bibr">10</xref>]. The overall prevalence of CHD in the five districts (6.28&#x02030;) was slightly lower than the prevalence (7.93&#x02030;) reported in our previous multicenter prospective screening study conducted at 15 birthing facilities in Shanghai, while the prevalence of life-threatening major CHD (1.20&#x02030;) in this study was comparable to that of our previous study (1.21&#x02030;) [<xref rid="B9-IJNS-11-00038" ref-type="bibr">9</xref>]. These findings suggest that while some CHD may be missed or underreported in clinical practice using the dual-index method, life-threatening major CHD cases are consistently identified. Overall, the high screening rate, echocardiography examination rate and the fact that 202 children with CHD received timely and effective treatment indicated that the newborn screening program for CHD has been well implemented in the five districts of south Shanghai and a sound integrated network for neonatal CHD screening, diagnosis and treatment has been established. These findings also underscored that, despite the challenges to the Shanghai healthcare system posed by COVID-19 [<xref rid="B14-IJNS-11-00038" ref-type="bibr">14</xref>], the newborn screening program for CHD effectively adapted to maintain high standards of care, ensuring the early detection and timely treatment of CHD in newborns.</p><p>In our study, the post-discharge diagnosis rate of CCHD was 4/100,000, which aligns with the results from our previous screening study in Shanghai [<xref rid="B9-IJNS-11-00038" ref-type="bibr">9</xref>] and a UK regional study [<xref rid="B15-IJNS-11-00038" ref-type="bibr">15</xref>], but lower than the rate in the rest of China [<xref rid="B3-IJNS-11-00038" ref-type="bibr">3</xref>,<xref rid="B8-IJNS-11-00038" ref-type="bibr">8</xref>]. The observed differences in the prevalence of CCHD may be attributed to a combination of advanced prenatal diagnosis and regional healthcare disparities. In Shanghai, prenatal diagnosis for CHD is a routine part of pregnancy management. A study by Zhang et al. (2020) found that regions like Zhejiang, which share a similar healthcare infrastructure to Shanghai, reported 90% prenatal detection rates for CCHD [<xref rid="B16-IJNS-11-00038" ref-type="bibr">16</xref>]. Additionally, genetic studies in Shanghai have shown a high incidence of chromosomal abnormalities in fetuses with CCHD [<xref rid="B17-IJNS-11-00038" ref-type="bibr">17</xref>], which may influence parental decisions regarding pregnancy termination [<xref rid="B18-IJNS-11-00038" ref-type="bibr">18</xref>]. Higher maternal education and access to advanced healthcare in Shanghai further contribute to the lower CCHD prevalence. [<xref rid="B19-IJNS-11-00038" ref-type="bibr">19</xref>].</p><p>POX screening for CCHD has been widely recommended and adopted in many countries [<xref rid="B20-IJNS-11-00038" ref-type="bibr">20</xref>]. In the present study, we found that POX had moderate sensitivity (84.93%) and high specificity (99.57%) for CCHD, consistent with our previous multicenter screening studies [<xref rid="B8-IJNS-11-00038" ref-type="bibr">8</xref>,<xref rid="B9-IJNS-11-00038" ref-type="bibr">9</xref>], and with findings from studies conducted in developed countries [<xref rid="B6-IJNS-11-00038" ref-type="bibr">6</xref>]. However, POX alone as a screening method was only able to identify only 38.08% of cases of major CHD. The sensitivity of POX screening for major CHD in this study was lower than that in our previous studies conducted at 15 birthing facilities in Shanghai (44.3%) [<xref rid="B9-IJNS-11-00038" ref-type="bibr">9</xref>], and 18 hospitals in 10 provinces of China (58.7%) [<xref rid="B3-IJNS-11-00038" ref-type="bibr">3</xref>], but higher than a 5-year observational study from the UK (33%) [<xref rid="B15-IJNS-11-00038" ref-type="bibr">15</xref>]. This study, along with previous research, suggested that POX alone as a screening method may lead to missed diagnoses of many major CHD cases, such as large ventricular septal defects and tetralogy of Fallot [<xref rid="B21-IJNS-11-00038" ref-type="bibr">21</xref>,<xref rid="B22-IJNS-11-00038" ref-type="bibr">22</xref>]. Therefore, all major CHD should be regarded as targets for newborn screening to prevent heart failure or irreversible pulmonary vascular disease.</p><p>In the present study, the sensitivity and specificity of the dual-index method was 100.00% and 98.38% for CCHD, which were consistent with the findings of our previous multicenter screening studies [<xref rid="B8-IJNS-11-00038" ref-type="bibr">8</xref>,<xref rid="B9-IJNS-11-00038" ref-type="bibr">9</xref>]. Although the sensitivity of the dual-index method for major CHD (86.19%) in this study was slightly lower than that in our previous studies [<xref rid="B8-IJNS-11-00038" ref-type="bibr">8</xref>,<xref rid="B9-IJNS-11-00038" ref-type="bibr">9</xref>], our findings demonstrated that the dual-index method could significantly improve the sensitivities for CCHD and major CHD compared to using POX testing alone. Additionally, the false-positive rates of the dual-index method for the detection of CCHD and major CHD remained at a low level. These findings provide valuable insights that address concerns in countries like the UK about the missed diagnosis of major CHD using only POX testing and the high false-positive rate. It is also noteworthy that the positive predictive value of the dual-index method for all types of CHD exceeded one-third, indicating that over 30 out of 100 infants with a positive screening result using the dual-index method would be diagnosed and treated in a timely manner. Infants with early detection of CHD may benefit from subsequent timely intervention and intensive surveillance [<xref rid="B10-IJNS-11-00038" ref-type="bibr">10</xref>]. Importantly, only 0.08% (139 of 195,307) of infants with negative screening results using the dual-index method were later diagnosed with CHD, of whom 33 were identified with major CHD, and there were no deaths among these infants. Over half of these false-negative infants (59.39%) were found to have a heart murmur during routine physical examination within six months after birth, suggesting that infants with negative screening results using the dual-index method should be aware of follow-up physical examination.</p><p>Our study has several strengths. First, the present study utilized real-world data from a five-year clinical practice across all delivery hospitals in the five administrative districts of Shanghai, which enhances the applicability of the results to everyday clinical practice. Second, our study comprehensively described the postnatal diagnoses of all types of CHD in infants with both positive and negative results using the dual-index method over a five-year period, and described what cardiac conditions lead to false-negative results using the dual-index method. Third, this study benefited from a relatively large sample size, enabling us to assess whether the accuracy of the dual-index method in clinical practice aligns with findings from our previous large-scale, prospective, multicenter screening studies. Inevitably, the present study also has several limitations. First, as a retrospective database study based on real-world clinical practice, it may be constrained by the lack of direct control and the inherent heterogeneity of the population. Second, 139 infants with negative screening results using the dual-index method were later diagnosed with CHD through clinical follow-up and medical chart review, which indicated that there was a possibility of false-negative results. Third, the low prevalence of CCHD in the current study would be expected to impact the positive predictive value of screening. Future studies should further validate the accuracy of the dual-index method in screening for CCHD in clinical practice.</p></sec><sec sec-type="conclusions" id="sec5-IJNS-11-00038"><title>5. Conclusions</title><p>In the present study, we detailed the progress and results of the newborn screening program for CHD in the five administrative districts of south Shanghai between 2019 and 2023, and demonstrated that newborn screening program for CHD has been effectively implemented. Additionally, this retrospective cohort study based on clinical practice further confirmed that the dual-index method had high sensitivity and specificity, and a low false-positive rate. Our study suggests that the dual-index method could be applied in common hospital settings in other regions, and that infants with negative screening results should be aware of follow-up physical examination.</p></sec></body><back><ack><title>Acknowledgments</title><p>We would like to thank all the medical staff involved in the Newborn Screening Program for Congenital Heart Disease in Shanghai.</p></ack><fn-group><fn><p><bold>Disclaimer/Publisher&#x02019;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><notes><title>Author Contributions</title><p>Conceptualization, project administration, and supervision, G.H. and Y.Y.; methodology and formal analysis, Y.T.; investigation and data curation, Q.G.; software and validation, X.H., X.G., X.M., M.Y. (Miao Yang) and P.J.; writing&#x02014;original draft preparation, Y.T.; writing&#x02014;review and editing, all authors; funding acquisition, G.H. and Y.T. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Institutional Review Board Statement</title><p>The study was conducted in accordance with the Declaration of Helsinki, and approved by the Institutional Review Board of Children&#x02019;s Hospital of Fudan University [2023 (132)] (Approval date: 20 June 2023).</p></notes><notes><title>Informed Consent Statement</title><p>Written informed consent was obtained from the patient(s) prior to publishing this paper.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>The datasets used and analyzed in this study are available from the corresponding author on reasonable request.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></notes><glossary><title>Abbreviations</title><array><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">CHD</td><td align="left" valign="middle" rowspan="1" colspan="1">Congenital heart disease</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">POX</td><td align="left" valign="middle" rowspan="1" colspan="1">Pulse oximetry</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">CCHD</td><td align="left" valign="middle" rowspan="1" colspan="1">Critical congenital heart disease</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">NICU</td><td align="left" valign="middle" rowspan="1" colspan="1">Neonatal intensive care unit</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">SpO<sub>2</sub></td><td align="left" valign="middle" rowspan="1" colspan="1">Pulse oximeter oxygen saturation</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">ASD</td><td align="left" valign="middle" rowspan="1" colspan="1">Atrial septal defect</td></tr></tbody></array></glossary><ref-list><title>References</title><ref id="B1-IJNS-11-00038"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<collab>Thoracic and Cardiovascular Surgery Branch of Chinese Medical Association</collab>
</person-group><article-title>National consensus in China on perinatal diagnosis, evaluation and clinical disposal of cardiac birth defects</article-title><source>Chin. J. Pediatr. Surg.</source><year>2018</year><volume>39</volume><fpage>163</fpage><lpage>170</lpage><comment>(In Chinese)</comment><pub-id pub-id-type="doi">10.3760/cma.j.issn.0253-3006.2018.03.002</pub-id></element-citation></ref><ref id="B2-IJNS-11-00038"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tian</surname><given-names>Y.</given-names></name>
<name><surname>Hu</surname><given-names>X.</given-names></name>
<name><surname>Gu</surname><given-names>Q.</given-names></name>
<name><surname>Yang</surname><given-names>M.</given-names></name>
<name><surname>Jia</surname><given-names>P.</given-names></name>
<name><surname>Ma</surname><given-names>X.</given-names></name>
<name><surname>Ge</surname><given-names>X.</given-names></name>
<name><surname>Zhao</surname><given-names>Q.</given-names></name>
<name><surname>Liu</surname><given-names>F.</given-names></name>
<name><surname>Ye</surname><given-names>M.</given-names></name>
<etal/>
</person-group><article-title>Temporal trend in mortality due to congenital heart disease in China from 2008 to 2021</article-title><source>Chin. Med. J.</source><year>2025</year><volume>138</volume><fpage>693</fpage><lpage>701</lpage><pub-id pub-id-type="doi">10.1097/CM9.0000000000003057</pub-id><pub-id pub-id-type="pmid">38663857</pub-id>
</element-citation></ref><ref id="B3-IJNS-11-00038"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhao</surname><given-names>Q.M.</given-names></name>
<name><surname>Liu</surname><given-names>F.</given-names></name>
<name><surname>Wu</surname><given-names>L.</given-names></name>
<name><surname>Ma</surname><given-names>X.J.</given-names></name>
<name><surname>Niu</surname><given-names>C.</given-names></name>
<name><surname>Huang</surname><given-names>G.Y.</given-names></name>
</person-group><article-title>Prevalence of Congenital Heart Disease at Live Birth in China</article-title><source>J. Pediatr.</source><year>2019</year><volume>204</volume><fpage>53</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1016/j.jpeds.2018.08.040</pub-id><pub-id pub-id-type="pmid">30270157</pub-id>
</element-citation></ref><ref id="B4-IJNS-11-00038"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Brown</surname><given-names>K.L.</given-names></name>
<name><surname>Ridout</surname><given-names>D.A.</given-names></name>
<name><surname>Hoskote</surname><given-names>A.</given-names></name>
<name><surname>Verhulst</surname><given-names>L.</given-names></name>
<name><surname>Ricci</surname><given-names>M.</given-names></name>
<name><surname>Bull</surname><given-names>C.</given-names></name>
</person-group><article-title>Delayed diagnosis of congenital heart disease worsens preoperative condition and outcome of surgery in neonates</article-title><source>Heart</source><year>2006</year><volume>92</volume><fpage>1298</fpage><lpage>1302</lpage><pub-id pub-id-type="doi">10.1136/hrt.2005.078097</pub-id><pub-id pub-id-type="pmid">16449514</pub-id>
</element-citation></ref><ref id="B5-IJNS-11-00038"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Liberman</surname><given-names>R.F.</given-names></name>
<name><surname>Getz</surname><given-names>K.D.</given-names></name>
<name><surname>Lin</surname><given-names>A.E.</given-names></name>
<name><surname>Higgins</surname><given-names>C.A.</given-names></name>
<name><surname>Sekhavat</surname><given-names>S.</given-names></name>
<name><surname>Markenson</surname><given-names>G.R.</given-names></name>
<name><surname>Anderka</surname><given-names>M.</given-names></name>
</person-group><article-title>Delayed Diagnosis of Critical Congenital Heart Defects: Trends and Associated Factors</article-title><source>Pediatrics</source><year>2014</year><volume>134</volume><fpage>E373</fpage><lpage>E381</lpage><pub-id pub-id-type="doi">10.1542/peds.2013-3949</pub-id><pub-id pub-id-type="pmid">25070301</pub-id>
</element-citation></ref><ref id="B6-IJNS-11-00038"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Plana</surname><given-names>M.N.</given-names></name>
<name><surname>Zamora</surname><given-names>J.</given-names></name>
<name><surname>Suresh</surname><given-names>G.</given-names></name>
<name><surname>Fernandez-Pineda</surname><given-names>L.</given-names></name>
<name><surname>Thangaratinam</surname><given-names>S.</given-names></name>
<name><surname>Ewer</surname><given-names>A.K.</given-names></name>
</person-group><article-title>Pulse oximetry screening for critical congenital heart defects</article-title><source>Cochrane Database Syst. Rev.</source><year>2018</year><volume>3</volume><fpage>CD011912</fpage><pub-id pub-id-type="doi">10.1002/14651858.CD011912.pub2</pub-id><pub-id pub-id-type="pmid">29494750</pub-id>
</element-citation></ref><ref id="B7-IJNS-11-00038"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Abouk</surname><given-names>R.</given-names></name>
<name><surname>Grosse</surname><given-names>S.D.</given-names></name>
<name><surname>Ailes</surname><given-names>E.C.</given-names></name>
<name><surname>Oster</surname><given-names>M.E.</given-names></name>
</person-group><article-title>Association of US State Implementation of Newborn Screening Policies for Critical Congenital Heart Disease with Early Infant Cardiac Deaths</article-title><source>JAMA-J. Am. Med. Assoc.</source><year>2017</year><volume>318</volume><fpage>2111</fpage><lpage>2118</lpage><pub-id pub-id-type="doi">10.1001/jama.2017.17627</pub-id></element-citation></ref><ref id="B8-IJNS-11-00038"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhao</surname><given-names>Q.M.</given-names></name>
<name><surname>Ma</surname><given-names>X.J.</given-names></name>
<name><surname>Ge</surname><given-names>X.L.</given-names></name>
<name><surname>Liu</surname><given-names>F.</given-names></name>
<name><surname>Yan</surname><given-names>W.L.</given-names></name>
<name><surname>Wu</surname><given-names>L.</given-names></name>
<name><surname>Ye</surname><given-names>M.</given-names></name>
<name><surname>Liang</surname><given-names>X.C.</given-names></name>
<name><surname>Zhang</surname><given-names>J.</given-names></name>
<name><surname>Gao</surname><given-names>Y.</given-names></name>
<etal/>
</person-group><article-title>Pulse oximetry with clinical assessment to screen for congenital heart disease in neonates in China: A prospective study</article-title><source>Lancet</source><year>2014</year><volume>384</volume><fpage>747</fpage><lpage>754</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(14)60198-7</pub-id><pub-id pub-id-type="pmid">24768155</pub-id>
</element-citation></ref><ref id="B9-IJNS-11-00038"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hu</surname><given-names>X.J.</given-names></name>
<name><surname>Ma</surname><given-names>X.J.</given-names></name>
<name><surname>Zhao</surname><given-names>Q.M.</given-names></name>
<name><surname>Yan</surname><given-names>W.L.</given-names></name>
<name><surname>Ge</surname><given-names>X.L.</given-names></name>
<name><surname>Jia</surname><given-names>B.</given-names></name>
<name><surname>Liu</surname><given-names>F.</given-names></name>
<name><surname>Wu</surname><given-names>L.</given-names></name>
<name><surname>Ye</surname><given-names>M.</given-names></name>
<name><surname>Liang</surname><given-names>X.C.</given-names></name>
<etal/>
</person-group><article-title>Pulse Oximetry and Auscultation for Congenital Heart Disease Detection</article-title><source>Pediatrics</source><year>2017</year><volume>140</volume><fpage>e20171154</fpage><pub-id pub-id-type="doi">10.1542/peds.2017-1154</pub-id><pub-id pub-id-type="pmid">28939700</pub-id>
</element-citation></ref><ref id="B10-IJNS-11-00038"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ma</surname><given-names>X.J.</given-names></name>
<name><surname>Tian</surname><given-names>Y.P.</given-names></name>
<name><surname>Ma</surname><given-names>F.C.</given-names></name>
<name><surname>Ge</surname><given-names>X.L.</given-names></name>
<name><surname>Gu</surname><given-names>Q.</given-names></name>
<name><surname>Huang</surname><given-names>M.</given-names></name>
<name><surname>Zhang</surname><given-names>Y.Q.</given-names></name>
<name><surname>Sun</surname><given-names>K.</given-names></name>
<name><surname>Hu</surname><given-names>X.J.</given-names></name>
<name><surname>Yang</surname><given-names>M.</given-names></name>
<etal/>
</person-group><article-title>Impact of Newborn Screening Programme for Congenital Heart Disease in Shanghai: A five-year observational study in 801,831 newborns</article-title><source>Lancet Reg. Health-West. Pac.</source><year>2023</year><volume>33</volume><fpage>100688</fpage><pub-id pub-id-type="doi">10.1016/j.lanwpc.2023.100688</pub-id><pub-id pub-id-type="pmid">37181527</pub-id>
</element-citation></ref><ref id="B11-IJNS-11-00038"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhou</surname><given-names>F.Y.</given-names></name>
<name><surname>Li</surname><given-names>C.</given-names></name>
<name><surname>Qin</surname><given-names>K.Z.</given-names></name>
<name><surname>Luo</surname><given-names>C.</given-names></name>
<name><surname>Huang</surname><given-names>H.F.</given-names></name>
<name><surname>Wu</surname><given-names>Y.T.</given-names></name>
</person-group><article-title>Delivery and neonatal outcomes of pregnant women during the Shanghai lockdown: A retrospective analysis</article-title><source>Front. Pediatr.</source><year>2023</year><volume>11</volume><elocation-id>992908</elocation-id><pub-id pub-id-type="doi">10.3389/fped.2023.992908</pub-id><pub-id pub-id-type="pmid">36816385</pub-id>
</element-citation></ref><ref id="B12-IJNS-11-00038"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Deng</surname><given-names>H.M.</given-names></name>
<name><surname>Jin</surname><given-names>Y.P.</given-names></name>
<name><surname>Sheng</surname><given-names>M.M.</given-names></name>
<name><surname>Liu</surname><given-names>M.</given-names></name>
<name><surname>Shen</surname><given-names>J.</given-names></name>
<name><surname>Qian</surname><given-names>W.</given-names></name>
<name><surname>Zou</surname><given-names>G.</given-names></name>
<name><surname>Liao</surname><given-names>Y.X.</given-names></name>
<name><surname>Liu</surname><given-names>T.F.</given-names></name>
<name><surname>Ling</surname><given-names>Y.</given-names></name>
<etal/>
</person-group><article-title>Safety and efficacy of COVID-19 vaccine immunization during pregnancy in 1024 pregnant women infected with the SARS-CoV-2 Omicron virus in Shanghai, China</article-title><source>Front. Immunol.</source><year>2024</year><volume>14</volume><elocation-id>1303058</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2023.1303058</pub-id><pub-id pub-id-type="pmid">38292486</pub-id>
</element-citation></ref><ref id="B13-IJNS-11-00038"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ewer</surname><given-names>A.K.</given-names></name>
<name><surname>Middleton</surname><given-names>L.J.</given-names></name>
<name><surname>Furmston</surname><given-names>A.T.</given-names></name>
<name><surname>Bhoyar</surname><given-names>A.</given-names></name>
<name><surname>Daniels</surname><given-names>J.P.</given-names></name>
<name><surname>Thangaratinam</surname><given-names>S.</given-names></name>
<name><surname>Deeks</surname><given-names>J.J.</given-names></name>
<name><surname>Khan</surname><given-names>K.S.</given-names></name>
<name><surname>Grp</surname><given-names>P.S.</given-names></name>
</person-group><article-title>Pulse oximetry screening for congenital heart defects in newborn infants (PulseOx): A test accuracy study</article-title><source>Lancet</source><year>2011</year><volume>378</volume><fpage>785</fpage><lpage>794</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(11)60753-8</pub-id><pub-id pub-id-type="pmid">21820732</pub-id>
</element-citation></ref><ref id="B14-IJNS-11-00038"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sun</surname><given-names>S.Y.</given-names></name>
<name><surname>Xie</surname><given-names>Z.</given-names></name>
<name><surname>Yu</surname><given-names>K.T.</given-names></name>
<name><surname>Jiang</surname><given-names>B.Q.</given-names></name>
<name><surname>Zheng</surname><given-names>S.W.</given-names></name>
<name><surname>Pan</surname><given-names>X.T.</given-names></name>
</person-group><article-title>COVID-19 and healthcare system in China: Challenges and progression for a sustainable future</article-title><source>Glob. Health</source><year>2021</year><volume>17</volume><fpage>14</fpage><pub-id pub-id-type="doi">10.1186/s12992-021-00665-9</pub-id><pub-id pub-id-type="pmid">33478558</pub-id>
</element-citation></ref><ref id="B15-IJNS-11-00038"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Singh</surname><given-names>Y.</given-names></name>
<name><surname>Chen</surname><given-names>S.E.</given-names></name>
</person-group><article-title>Impact of pulse oximetry screening to detect congenital heart defects: 5 years&#x02019; experience in a UK regional neonatal unit</article-title><source>Eur. J. Pediatr.</source><year>2022</year><volume>181</volume><fpage>813</fpage><lpage>821</lpage><pub-id pub-id-type="doi">10.1007/s00431-021-04275-w</pub-id><pub-id pub-id-type="pmid">34618229</pub-id>
</element-citation></ref><ref id="B16-IJNS-11-00038"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>X.H.</given-names></name>
<name><surname>Sun</surname><given-names>Y.</given-names></name>
<name><surname>Zhu</surname><given-names>J.J.</given-names></name>
<name><surname>Zhu</surname><given-names>Y.N.</given-names></name>
<name><surname>Qiu</surname><given-names>L.Q.</given-names></name>
</person-group><article-title>Epidemiology, prenatal diagnosis, and neonatal outcomes of congenital heart defects in eastern China: A hospital-based multicenter study</article-title><source>BMC Pediatr.</source><year>2020</year><volume>20</volume><elocation-id>416</elocation-id><pub-id pub-id-type="doi">10.1186/s12887-020-02313-4</pub-id><pub-id pub-id-type="pmid">32878605</pub-id>
</element-citation></ref><ref id="B17-IJNS-11-00038"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Li</surname><given-names>M.</given-names></name>
<name><surname>Ye</surname><given-names>B.</given-names></name>
<name><surname>Chen</surname><given-names>Y.</given-names></name>
<name><surname>Gao</surname><given-names>L.</given-names></name>
<name><surname>Wu</surname><given-names>Y.</given-names></name>
<name><surname>Cheng</surname><given-names>W.</given-names></name>
</person-group><article-title>Analysis of genetic testing in fetuses with congenital heart disease of single atria and/or single ventricle in a Chinese prenatal cohort</article-title><source>BMC Pediatr.</source><year>2023</year><volume>23</volume><elocation-id>577</elocation-id><pub-id pub-id-type="doi">10.1186/s12887-023-04382-7</pub-id><pub-id pub-id-type="pmid">37980516</pub-id>
</element-citation></ref><ref id="B18-IJNS-11-00038"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tomek</surname><given-names>V.</given-names></name>
<name><surname>Jicinska</surname><given-names>H.</given-names></name>
<name><surname>Pavlicek</surname><given-names>J.</given-names></name>
<name><surname>Kovanda</surname><given-names>J.</given-names></name>
<name><surname>Jehlicka</surname><given-names>P.</given-names></name>
<name><surname>Klaskova</surname><given-names>E.</given-names></name>
<name><surname>Mrazek</surname><given-names>J.</given-names></name>
<name><surname>Cutka</surname><given-names>D.</given-names></name>
<name><surname>Smetanova</surname><given-names>D.</given-names></name>
<name><surname>Brestak</surname><given-names>M.</given-names></name>
<etal/>
</person-group><article-title>Pregnancy Termination and Postnatal Major Congenital Heart Defect Prevalence After Introduction of Prenatal Cardiac Screening</article-title><source>JAMA Netw. Open</source><year>2023</year><volume>6</volume><fpage>e2334069</fpage><pub-id pub-id-type="doi">10.1001/jamanetworkopen.2023.34069</pub-id><pub-id pub-id-type="pmid">37713196</pub-id>
</element-citation></ref><ref id="B19-IJNS-11-00038"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Liu</surname><given-names>Y.J.</given-names></name>
<name><surname>Chen</surname><given-names>S.</given-names></name>
<name><surname>Z&#x000fc;hlke</surname><given-names>L.</given-names></name>
<name><surname>Black</surname><given-names>G.C.</given-names></name>
<name><surname>Choy</surname><given-names>M.K.</given-names></name>
<name><surname>Li</surname><given-names>N.X.</given-names></name>
<name><surname>Keavney</surname><given-names>B.D.</given-names></name>
</person-group><article-title>Global birth prevalence of congenital heart defects 1970-2017: Updated systematic review and meta-analysis of 260 studies</article-title><source>Int. J. Epidemiol.</source><year>2019</year><volume>48</volume><fpage>455</fpage><lpage>463</lpage><pub-id pub-id-type="doi">10.1093/ije/dyz009</pub-id><pub-id pub-id-type="pmid">30783674</pub-id>
</element-citation></ref><ref id="B20-IJNS-11-00038"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Abbas</surname><given-names>A.</given-names></name>
<name><surname>Ewer</surname><given-names>A.K.</given-names></name>
</person-group><article-title>New born pulse oximetry screening: A global perspective</article-title><source>Early Hum. Dev.</source><year>2021</year><volume>162</volume><fpage>105457</fpage><pub-id pub-id-type="doi">10.1016/j.earlhumdev.2021.105457</pub-id><pub-id pub-id-type="pmid">34548207</pub-id>
</element-citation></ref><ref id="B21-IJNS-11-00038"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ailes</surname><given-names>E.C.</given-names></name>
<name><surname>Gilboa</surname><given-names>S.M.</given-names></name>
<name><surname>Honein</surname><given-names>M.A.</given-names></name>
<name><surname>Oster</surname><given-names>M.E.</given-names></name>
</person-group><article-title>Estimated Number of Infants Detected and Missed by Critical Congenital Heart Defect Screening</article-title><source>Pediatrics</source><year>2015</year><volume>135</volume><fpage>1000</fpage><lpage>1008</lpage><pub-id pub-id-type="doi">10.1542/peds.2014-3662</pub-id><pub-id pub-id-type="pmid">25963011</pub-id>
</element-citation></ref><ref id="B22-IJNS-11-00038"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Oddie</surname><given-names>S.</given-names></name>
<name><surname>Stenson</surname><given-names>B.</given-names></name>
<name><surname>Wyllie</surname><given-names>J.</given-names></name>
<name><surname>Ewer</surname><given-names>A.K.</given-names></name>
</person-group><article-title>UK consultation on pulse oximetry screening for critical congenital heart defects in newborns</article-title><source>Lancet</source><year>2019</year><volume>394</volume><fpage>103</fpage><lpage>104</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(19)31515-6</pub-id><pub-id pub-id-type="pmid">31272689</pub-id>
</element-citation></ref></ref-list></back><floats-group><fig position="float" id="IJNS-11-00038-f001"><label>Figure 1</label><caption><p>Profile of newborn screening for congenital heart disease in the five districts of Xuhui, Minhang, Songjiang, Jinshan and Qingpu in Shanghai. Note: CHD, congenital heart disease; POX, pulse oximetry.</p></caption><graphic xlink:href="IJNS-11-00038-g001" position="float"/></fig><fig position="float" id="IJNS-11-00038-f002"><label>Figure 2</label><caption><p>Time trends in newborn screening rate and echocardiography examination rate for congenital heart disease in the five districts of Xuhui, Minhang, Songjiang, Jinshan and Qingpu from 2019 to 2023.</p></caption><graphic xlink:href="IJNS-11-00038-g002" position="float"/></fig><table-wrap position="float" id="IJNS-11-00038-t001"><object-id pub-id-type="pii">IJNS-11-00038-t001_Table 1</object-id><label>Table 1</label><caption><p>Results of the newborn screening program for CHD in the five districts of Xuhui, Minhang, Songjiang, Jinshan and Qingpu in Shanghai from 2019 to 2023.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">District</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Number of Newborns</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Number of Newborns Screened</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Screening Rate (%)</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Number of Newborns Screened Positive</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Screened Positive Rate (%)</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Number of Echocardiography in Newborns Screened Positive</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Echocardiography Examination Rate (%)</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Number of Diagnosed CHD in Those Screened Positive</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Diagnostic Rate of CHD in Newborns Screened Positive (%)</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Number of False-Negative Cases</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">CHD Cases</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Prevalence of CHD (&#x02030;)</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Number of Treatments</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">Xuhui</td><td align="left" valign="middle" rowspan="1" colspan="1">84,884</td><td align="left" valign="middle" rowspan="1" colspan="1">84,783</td><td align="left" valign="middle" rowspan="1" colspan="1">99.88</td><td align="left" valign="middle" rowspan="1" colspan="1">1210</td><td align="left" valign="middle" rowspan="1" colspan="1">1.43</td><td align="left" valign="middle" rowspan="1" colspan="1">1103</td><td align="left" valign="middle" rowspan="1" colspan="1">91.16</td><td align="left" valign="middle" rowspan="1" colspan="1">463</td><td align="left" valign="middle" rowspan="1" colspan="1">38.26</td><td align="left" valign="middle" rowspan="1" colspan="1">26</td><td align="left" valign="middle" rowspan="1" colspan="1">489</td><td align="left" valign="middle" rowspan="1" colspan="1">5.76</td><td align="left" valign="middle" rowspan="1" colspan="1">60</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Qingpu</td><td align="left" valign="middle" rowspan="1" colspan="1">10,304</td><td align="left" valign="middle" rowspan="1" colspan="1">10,301</td><td align="left" valign="middle" rowspan="1" colspan="1">99.97</td><td align="left" valign="middle" rowspan="1" colspan="1">193</td><td align="left" valign="middle" rowspan="1" colspan="1">1.87</td><td align="left" valign="middle" rowspan="1" colspan="1">180</td><td align="left" valign="middle" rowspan="1" colspan="1">93.26</td><td align="left" valign="middle" rowspan="1" colspan="1">56</td><td align="left" valign="middle" rowspan="1" colspan="1">29.02</td><td align="left" valign="middle" rowspan="1" colspan="1">4</td><td align="left" valign="middle" rowspan="1" colspan="1">60</td><td align="left" valign="middle" rowspan="1" colspan="1">5.82</td><td align="left" valign="middle" rowspan="1" colspan="1">15</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Jinshan</td><td align="left" valign="middle" rowspan="1" colspan="1">17,925</td><td align="left" valign="middle" rowspan="1" colspan="1">17,891</td><td align="left" valign="middle" rowspan="1" colspan="1">99.81</td><td align="left" valign="middle" rowspan="1" colspan="1">459</td><td align="left" valign="middle" rowspan="1" colspan="1">2.57</td><td align="left" valign="middle" rowspan="1" colspan="1">420</td><td align="left" valign="middle" rowspan="1" colspan="1">91.50</td><td align="left" valign="middle" rowspan="1" colspan="1">110</td><td align="left" valign="middle" rowspan="1" colspan="1">23.97</td><td align="left" valign="middle" rowspan="1" colspan="1">27</td><td align="left" valign="middle" rowspan="1" colspan="1">137</td><td align="left" valign="middle" rowspan="1" colspan="1">7.64</td><td align="left" valign="middle" rowspan="1" colspan="1">27</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Minhang</td><td align="left" valign="middle" rowspan="1" colspan="1">34,262</td><td align="left" valign="middle" rowspan="1" colspan="1">34,235</td><td align="left" valign="middle" rowspan="1" colspan="1">99.92</td><td align="left" valign="middle" rowspan="1" colspan="1">547</td><td align="left" valign="middle" rowspan="1" colspan="1">1.60</td><td align="left" valign="middle" rowspan="1" colspan="1">527</td><td align="left" valign="middle" rowspan="1" colspan="1">96.34</td><td align="left" valign="middle" rowspan="1" colspan="1">220</td><td align="left" valign="middle" rowspan="1" colspan="1">40.22</td><td align="left" valign="middle" rowspan="1" colspan="1">41</td><td align="left" valign="middle" rowspan="1" colspan="1">261</td><td align="left" valign="middle" rowspan="1" colspan="1">7.62</td><td align="left" valign="middle" rowspan="1" colspan="1">37</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Songjiang</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">51,450</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">51,396</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">99.90</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">890</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.73</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">813</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">91.35</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">260</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">29.21</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">41</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">301</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.85</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">63</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Total</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">198,825</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">198,606</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">99.89 </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3299</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.66 </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3043</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">92.24 </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1109</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">33.62 </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">139</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1248</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6.28 </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">202</td></tr></tbody></table><table-wrap-foot><fn><p>Note: (1) screening rate = number of newborns screened/number of newborns &#x000d7; 100%; (2) screened positive rate = number of newborns screened positive/number of newborns screened &#x000d7; 100%; (3) echocardiography examination rate = number of echocardiography in newborns screened positive/number of newborns screened positive &#x000d7; 100%; (4) diagnostic rate of CHD in newborns screened positive = number of newborns diagnosed CHD in those screened positive/number of newborns screened positive &#x000d7; 100%; (5) prevalence of CHD = number of CHD cases/number of live births &#x000d7; 100%. CHD, congenital heart disease.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="IJNS-11-00038-t002"><object-id pub-id-type="pii">IJNS-11-00038-t002_Table 2</object-id><label>Table 2</label><caption><p>Types of life-threatening major congenital heart disease in infants with positive and negative screening results using the dual-index method.</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="2" align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">CHD in Infants with Positive Screening Results</th><th colspan="2" align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">CHD in Infants with Negative Screening Results</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">Critical CHD (N = 73)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="left" valign="middle" rowspan="1" colspan="1">Serious CHD (N = 33)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Pulmonary atresia</td><td align="left" valign="middle" rowspan="1" colspan="1">20</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Patent ductus arteriosus</td><td align="left" valign="middle" rowspan="1" colspan="1">17</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Total anomalous pulmonary venous drainage</td><td align="left" valign="middle" rowspan="1" colspan="1">16</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Ventricular septal defect</td><td align="left" valign="middle" rowspan="1" colspan="1">12</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Coarctation of the aorta</td><td align="left" valign="middle" rowspan="1" colspan="1">11</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Atrioventricular septal defect</td><td align="left" valign="middle" rowspan="1" colspan="1">1</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Transposition of the great arteries</td><td align="left" valign="middle" rowspan="1" colspan="1">10</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Coarctation of the aorta</td><td align="left" valign="middle" rowspan="1" colspan="1">1</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Critical pulmonary stenosis</td><td align="left" valign="middle" rowspan="1" colspan="1">7</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Cor triatriatum</td><td align="left" valign="middle" rowspan="1" colspan="1">1</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Interrupted aortic arch</td><td align="left" valign="middle" rowspan="1" colspan="1">3</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Partial anomalous pulmonary venous connection</td><td align="left" valign="middle" rowspan="1" colspan="1">1</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Double outlet right ventricle</td><td align="left" valign="middle" rowspan="1" colspan="1">2</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Hypoplastic left heart syndrome</td><td align="left" valign="middle" rowspan="1" colspan="1">2</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Single ventricle</td><td align="left" valign="middle" rowspan="1" colspan="1">2</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Serious CHD (N = 133)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Ventricular septal defect</td><td align="left" valign="middle" rowspan="1" colspan="1">71</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Tetralogy of Fallot</td><td align="left" valign="middle" rowspan="1" colspan="1">20</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Pulmonary stenosis</td><td align="left" valign="middle" rowspan="1" colspan="1">18</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Patent ductus arteriosus</td><td align="left" valign="middle" rowspan="1" colspan="1">15</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Atrioventricular septal defect</td><td align="left" valign="middle" rowspan="1" colspan="1">6</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Coarctation of the aorta</td><td align="left" valign="middle" rowspan="1" colspan="1">2</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> &#x02003;Partial anomalous pulmonary venous connection</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr></tbody></table><table-wrap-foot><fn><p>Note: CHD, congenital heart disease.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="IJNS-11-00038-t003"><object-id pub-id-type="pii">IJNS-11-00038-t003_Table 3</object-id><label>Table 3</label><caption><p>Accuracy of screening methods for detecting critical and major congenital heart disease, and all types of congenital heart disease (N = 198,606).</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">
</th><th colspan="2" align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">CCHD</th><th colspan="2" align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Major CHD </th><th colspan="2" align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">All Type of CHD</th></tr><tr><th align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">POX Alone</th><th align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dual-Index Method</th><th align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">POX Alone</th><th align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dual-Index Method</th><th align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">POX Alone</th><th align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dual-Index Method</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">True-positives</td><td align="left" valign="middle" rowspan="1" colspan="1">62</td><td align="left" valign="middle" rowspan="1" colspan="1">73</td><td align="left" valign="middle" rowspan="1" colspan="1">91</td><td align="left" valign="middle" rowspan="1" colspan="1">206</td><td align="left" valign="middle" rowspan="1" colspan="1">231</td><td align="left" valign="middle" rowspan="1" colspan="1">1109</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">False-negatives</td><td align="left" valign="middle" rowspan="1" colspan="1">11</td><td align="left" valign="middle" rowspan="1" colspan="1">0</td><td align="left" valign="middle" rowspan="1" colspan="1">148</td><td align="left" valign="middle" rowspan="1" colspan="1">33</td><td align="left" valign="middle" rowspan="1" colspan="1">1017</td><td align="left" valign="middle" rowspan="1" colspan="1">139</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">False-positives</td><td align="left" valign="middle" rowspan="1" colspan="1">851</td><td align="left" valign="middle" rowspan="1" colspan="1">3226</td><td align="left" valign="middle" rowspan="1" colspan="1">822</td><td align="left" valign="middle" rowspan="1" colspan="1">3093</td><td align="left" valign="middle" rowspan="1" colspan="1">682</td><td align="left" valign="middle" rowspan="1" colspan="1">2190</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">True-negatives</td><td align="left" valign="middle" rowspan="1" colspan="1">197,682</td><td align="left" valign="middle" rowspan="1" colspan="1">195,307</td><td align="left" valign="middle" rowspan="1" colspan="1">197,545</td><td align="left" valign="middle" rowspan="1" colspan="1">195,274</td><td align="left" valign="middle" rowspan="1" colspan="1">196,676</td><td align="left" valign="middle" rowspan="1" colspan="1">195,168</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">False-positive rate (%)</td><td align="left" valign="middle" rowspan="1" colspan="1">0.43</td><td align="left" valign="middle" rowspan="1" colspan="1">1.62</td><td align="left" valign="middle" rowspan="1" colspan="1">0.41</td><td align="left" valign="middle" rowspan="1" colspan="1">1.56</td><td align="left" valign="middle" rowspan="1" colspan="1">0.34</td><td align="left" valign="middle" rowspan="1" colspan="1">1.11</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Sensitivity (%)</td><td align="left" valign="middle" rowspan="1" colspan="1">84.93 (75.00, 91.37)</td><td align="left" valign="middle" rowspan="1" colspan="1">100.00 (95.00, 100.00) *</td><td align="left" valign="middle" rowspan="1" colspan="1">38.08 (32.15, 44.37)</td><td align="left" valign="middle" rowspan="1" colspan="1">86.19 (81.24, 90.00) *</td><td align="left" valign="middle" rowspan="1" colspan="1">18.51 (16.45, 20.76)</td><td align="left" valign="middle" rowspan="1" colspan="1">88.86 (87.00, 90.49) *</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Specificity (%)</td><td align="left" valign="middle" rowspan="1" colspan="1">99.57 (99.54, 99.60)</td><td align="left" valign="middle" rowspan="1" colspan="1">98.38 (98.32, 98.43)</td><td align="left" valign="middle" rowspan="1" colspan="1">99.59 (99.56, 99.61)</td><td align="left" valign="middle" rowspan="1" colspan="1">98.44 (98.39, 98.49)</td><td align="left" valign="middle" rowspan="1" colspan="1">99.65 (99.63, 99.68)</td><td align="left" valign="middle" rowspan="1" colspan="1">98.89 (98.84, 98.94)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Positive predictive value (%)</td><td align="left" valign="middle" rowspan="1" colspan="1">6.79 (5.33, 8.61)</td><td align="left" valign="middle" rowspan="1" colspan="1">2.21 (1.76, 2.77)</td><td align="left" valign="middle" rowspan="1" colspan="1">9.97 (8.19, 12.08)</td><td align="left" valign="middle" rowspan="1" colspan="1">6.24 (5.47, 7.12)</td><td align="left" valign="middle" rowspan="1" colspan="1">25.30 (22.59, 28.22)</td><td align="left" valign="middle" rowspan="1" colspan="1">33.62 (32.02, 35.25)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Negative predictive value (%)</td><td align="left" valign="middle" rowspan="1" colspan="1">99.99 (99.99, 100.00)</td><td align="left" valign="middle" rowspan="1" colspan="1">100.00 (100.00, 100.00)</td><td align="left" valign="middle" rowspan="1" colspan="1">99.93 (99.91, 99.94)</td><td align="left" valign="middle" rowspan="1" colspan="1">99.98 (99.98, 99.99)</td><td align="left" valign="middle" rowspan="1" colspan="1">99.49 (99.45, 99.52)</td><td align="left" valign="middle" rowspan="1" colspan="1">99.93 (99.92, 99.94)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Consistency rate (%)</td><td align="left" valign="middle" rowspan="1" colspan="1">99.57 (99.54, 99.59)</td><td align="left" valign="middle" rowspan="1" colspan="1">98.38 (98.32, 98.43)</td><td align="left" valign="middle" rowspan="1" colspan="1">99.51 (99.48, 99.54)</td><td align="left" valign="middle" rowspan="1" colspan="1">98.43 (98.37, 98.48)</td><td align="left" valign="middle" rowspan="1" colspan="1">99.14 (99.1, 99.18)</td><td align="left" valign="middle" rowspan="1" colspan="1">98.83 (98.78, 98.87)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Youden&#x02019;s index</td><td align="left" valign="middle" rowspan="1" colspan="1">0.85</td><td align="left" valign="middle" rowspan="1" colspan="1">0.98</td><td align="left" valign="middle" rowspan="1" colspan="1">0.38</td><td align="left" valign="middle" rowspan="1" colspan="1">0.85</td><td align="left" valign="middle" rowspan="1" colspan="1">0.18</td><td align="left" valign="middle" rowspan="1" colspan="1">0.88</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Positive likelihood ratio</td><td align="left" valign="middle" rowspan="1" colspan="1">197.91</td><td align="left" valign="middle" rowspan="1" colspan="1">61.54</td><td align="left" valign="middle" rowspan="1" colspan="1">91.88</td><td align="left" valign="middle" rowspan="1" colspan="1">55.28</td><td align="left" valign="middle" rowspan="1" colspan="1">53.56</td><td align="left" valign="middle" rowspan="1" colspan="1">80.08</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Negative likelihood ratio</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15.13</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.00</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">62.18</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14.03</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">81.77</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11.26</td></tr></tbody></table><table-wrap-foot><fn><p>Note: CHD, congenital heart disease; POX, pulse oximetry; major CHD includes critical CHD and serious CHD. * Statistically significant (<italic toggle="yes">p</italic> &#x0003c; 0.05) using McNemar&#x02019;s test compare differences in specificity between POX and the dual-index method.</p></fn></table-wrap-foot></table-wrap></floats-group></article>